Echocardiographic assessment of hypertensive patients with or without hyperhomocysteinemia

Huan Zheng1, Ye Li, Nanzi Xie

  • 1Geriatrics Department, Tongji Hospital affiliated to Tongji University , Shanghai , China .

Insights

Hyperhomocysteinemia (Hhcy) exacerbates hypertension-induced myocardial impairment, particularly affecting left ventricular diastolic function. Elevated homocysteine levels correlate significantly with diastolic dysfunction parameters in hypertensive patients.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Biochemistry

Background:

  • Hypertension is a major risk factor for cardiovascular disease.
  • Hyperhomocysteinemia (Hhcy) is an independent risk factor for atherosclerosis and thrombosis.
  • The combined impact of hypertension and Hhcy on cardiac function requires further investigation.

Purpose of the Study:

  • To assess left ventricular (LV) systolic and diastolic function in hypertensive patients with or without Hhcy.
  • To determine the influence of Hhcy on cardiac function parameters in hypertensive individuals.
  • To explore the relationship between serum homocysteine levels and LV diastolic dysfunction.

Main Methods:

  • Echocardiography was used to evaluate cardiac function in 40 hypertensive patients with Hhcy, 40 hypertensive patients without Hhcy, and 40 healthy controls.
  • Key parameters measured included left atrial volume index (LAVI), interventricular septum thickness (IVST), posterior ventricular septum thickness (PVST), left ventricular mass index (LVMI), E/A ratio, deceleration time (DT), isovolumic relaxation time (IRT), and the Tei index.
  • Statistical analysis was performed to compare groups and assess correlations between homocysteine levels and cardiac function parameters.

Main Results:

  • Hypertensive patients, with or without Hhcy, exhibited impaired cardiac function compared to controls, indicated by higher Tei index values.
  • Significant differences were observed between hypertensive patients with Hhcy and those without, particularly in LAVI, E/A ratio, DT, IRT, and Tei index.
  • Serum homocysteine levels showed significant correlations with LV diastolic function parameters, including LAVI, E/A, DT, and IRT (p < 0.05).

Conclusions:

  • Hyperhomocysteinemia contributes to myocardial impairment in hypertensive patients.
  • Elevated homocysteine levels are strongly associated with left ventricular diastolic dysfunction in the context of hypertension.
  • These findings highlight the importance of managing Hhcy in hypertensive individuals to prevent cardiac complications.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion, evaluates...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...